# DESCRIPTION

## STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

- disclose government rights in invention

## BACKGROUND OF THE INVENTION

- describe sPLA2-IIA role in inflammatory diseases

## BRIEF SUMMARY OF THE INVENTION

- introduce method for identifying inhibitor for integrin-sPLA2-IIA binding

## DEFINITIONS

- define inflammation and inflammatory response
- define inflammatory condition
- define sPLA2-IIA protein and polynucleotide
- define integrin chains αv, α4, β1, and β3
- define inhibitors of sPLA2-IIA and integrin binding
- define effective amount and therapeutically effective amount
- define subject and nucleic acid

## DETAILED DESCRIPTION OF THE INVENTION

### I. Introduction

- introduce phospholipase A2 (PLA2) family
- describe biological effects of sPLA2-IIA

### II. Recombinant Expression of Polypeptides

- introduce general recombinant technology
- describe cloning and subcloning of coding sequence
- outline modification of polynucleotide coding sequence
- discuss modification of nucleic acids for preferred codon usage
- describe chemical synthesis of polypeptides

### III. Expression and Purification of Recombinant Polypeptides

- describe expression systems
- outline expression vector components
- discuss transfection methods
- summarize purification of recombinantly produced polypeptides
- describe purification of inclusion bodies
- outline standard protein separation techniques
- detail column chromatography

### IV. Inhibitors of sPLA2-IIA and Integrin Binding

- introduce inhibitory nucleic acids
- describe mechanisms of inhibitory nucleic acids
- introduce inactivating antibodies
- describe inactivating antibody fragments
- introduce identification of sPLA2-IIA and integrin binding inhibitors
- describe screening assays for inhibitors
- discuss combinatorial chemical libraries

### V. Inflammatory Responses and Conditions

- describe inflammatory responses and conditions

### VI. Pharmaceutical Compositions and Administration

- introduce pharmaceutical compositions
- describe routes of administration
- discuss formulation and dosage of pharmaceutical compositions

### VII. Therapeutic Applications Using Nucleic Acids

- describe therapeutic approaches for inflammatory conditions
- introduce vectors for nucleic acid delivery
- discuss gene delivery systems
- outline pharmaceutical formulations
- describe administration of formulations

### VIII. Kits

- describe kits for treating or preventing inflammatory conditions

## EXAMPLES

- describe experimental procedures

### Experimental Procedures

- synthesize and purify sPLA2-IIA
- perform binding assays and cell proliferation studies

### Results

- demonstrate sPLA2-IIA binding to integrin αvβ3
- perform docking simulation of sPLA2-IIA and integrin αvβ3 interaction
- test effects of sPLA2-IIA mutations on integrin binding and cell proliferation
- show sPLA2-IIA-induced cell proliferation is integrin-dependent

### Discussion

- establish sPLA2-IIA binding to integrin αvβ3
- discuss integrin αvβ3 expression and role in diseases

